主要文件

查看所有文档

53838-U

Ascentis^® Express 90Å C8 (2.7 μm) HPLC Columns

Name: Ascentis<SUP>&#174;</SUP> Express 90Å C8 (2.7 μm) HPLC Columns
Brand: SUPELCO

L × I.D. 15 cm × 4.6 mm, HPLC Column

别名:

核壳(SPP)实心核C8 HPLC色谱柱

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:

41115700

eCl@ss:

32110501

NACRES:

SB.52

L × i.d.:

15 cm × 4.6 mm

Particle size:

2.7 μm

Matrix active group:

C8 (octyl) phase

Pore size:

90 Å

Matrix:

Fused-Core particle platform, superficially porous particle

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

产品名称

Ascentis ^® Express C8，2.7μm HPLC 色谱柱, 2.7 μm particle size, L × I.D. 15 cm × 4.6 mm

material

stainless steel column

Quality Level

100

agency

suitable for USP L7

product line

Ascentis^®

feature

endcapped

manufacturer/tradename

Ascentis^®

packaging

1 ea of

parameter

60 °C temp. range, 600 bar max. pressure (9000 psi)

technique(s)

HPLC: suitable, LC/MS: suitable, UHPLC-MS: suitable, UHPLC: suitable

L × I.D.

15 cm × 4.6 mm

surface area

135 m²/g

impurities

<5 ppm metals

matrix

Fused-Core particle platform, superficially porous particle

matrix active group

C8 (octyl) phase

particle size

2.7 μm

pore size

90 Å

operating pH range

2-9

application(s)

food and beverages

separation technique

reversed phase

说明

General description

通过使用Fused-Core^® 粒子技术，Ascentis Express HPLC色谱柱在保持较低的反压力的同时，可以为您提供2μm以下颗粒的高速和高效率。高效率和低背压的结合可使UPLC^® （或其他超高压系统）用户，以及常规HPLC用户受益。
访问 Ascentis Express 主页，以获得有关此新色谱柱技术的更多信息。

Application

Recent trends in ultra-fast HPLC: new generation superficially porous silica columns.：综述高效液相色谱(HPLC)表面多孔硅胶柱的发展和性能，包括类似Ascentis Express(C8, 2.7 μm)的色谱柱。体现先进技术对分析速度和效率的影响(Ali et al., 2012)。

Development and validation of an HPLC-MS/MS method to determine clopidogrel in human plasma.Use of incurred samples to test back-conversion.：使用Ascentis Expresss(C8, 2.7 μm）等色谱柱开发HPLC-MS/MS分析方法以定量血浆中的氯吡格雷。说明柱子可用于临床药动学评估(Silvestro et al., 2010)。

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

Fused-Core is a registered trademark of Advanced Materials Technology, Inc.

UPLC is a registered trademark of Waters

Still not finding the right product?

Explore all of our products under Ascentis ^® Express C8，2.7μm HPLC 色谱柱

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

实验方案

US EPA Method 632: HPLC Analysis of Pesticides on Ascentis® C18

-methylcarbamate 10 μg/mL; Diuron; Propham; Siduron; Methiocarb, analytical standard; Linuron 10 μg/mL; Swep 10 μg/mL; Chlorpropham 10 μg/mL; Barban; Neburon

商品

Ascentis® Express C8 U/HPLC Columns

When a C18 doesn′t give the desired separation, or your sample contains compounds that are known to be difficult to retain or resolve on a C18, consider changing to an Ascentis® Express C8 column.

Quality by design approach for the separation of naproxcinod and its related substances by fused core particle technology column.

Ugandar Reddy Inugala et al.

Journal of chromatographic science, 51(5), 453-459 (2012-10-13)

This paper describes the development of a rapid, novel, stability-indicating gradient reversed-phase high-performance liquid chromatographic method and associated system suitability parameters for the analysis of naproxcinod in the presence of its related substances and degradents using a quality-by-design approach. All

Gradient RP-HPLC method for the determination of potential impurities in atazanavir sulfate.

Sreenivasa Rao Chitturi et al.

Journal of pharmaceutical and biomedical analysis, 55(1), 31-47 (2011-02-15)

This paper proposes a simple and selective RP-HPLC method for the determination of process impurities and degradation products (degradants) of atazanavir sulfate (ATV) drug substance. Chromatographic separation was achieved on Ascentis(®) Express C8, (150mm×4.6mm, 2.7μm) column thermostated at 30°C under

Development and validation of an HPLC-MS/MS method to determine clopidogrel in human plasma. Use of incurred samples to test back-conversion.

Luigi Silvestro et al.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 878(30), 3134-3142 (2010-10-20)

Quantitative methods using LC-MS/MS allow achievement of adequate sensitivity for pharmacokinetic studies with clopidogrel; three such methods, with LLOQs as low as 5 pg/mL, were developed and fully validated according to the well established FDA 2001 guidelines. The chromatographic separations

查看所有相关文献

全球贸易项目编号

货号	GTIN
53838-U	04061838534385